Patent · US Active

Non-invasive diagnostic biomarker for pancreatic islet populations

US11389106B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 17, 2018
Grant dateJul 19, 2022
Priority date
Expiry dateOct 17, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01R33/4616
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aspects of the disclosure relate to systems and methods for obtaining and interpreting magnetic resonance spectroscopy (MRS) data obtained from the pancreas of a subject. In some embodiments, systems and methods of the disclosure relate to analyzing MRS spectra of metabolites, for example y-Aminobutyric acid (GABA), to assess pancreatic islet density and function in a subject. In some embodiments, systems and methods described by the disclosure are useful for the diagnosis and/or treatment of diseases associated with impaired pancreatic function, for example diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.